Medifast (MED) Q1 2024 Earnings
MED·Reported April 29, 2024·After market close
Medifast reported Q1 2024 revenue of $174.7M, beat analyst consensus of $157.4M by $17.4M. Diluted EPS came in at $0.66, missed the $0.78 consensus by $0.12.
Revenue
$174.7Mbeat by $17.4M
Consensus: $157.4MDiluted EPS
$0.66missed by $0.12
Consensus: $0.78
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Medifast's Q1 2024 earnings report.
Medifast (MED) reported Q1 2024 earnings on April 29, 2024 after market close.
Medifast reported revenue of $174.7M and diluted EPS of $0.66 for Q1 2024.
Revenue beat the consensus estimate of $157.4M by $17.4M. EPS missed the consensus estimate of $0.78 by $0.12.
You can read the 10-Q periodic report (0001628280-24-019046) directly on SEC EDGAR. The filing index links above go to sec.gov.